[HTML][HTML] Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

BP Imbimbo, S Ippati, M Watling, C Imbimbo - Pharmacological research, 2023 - Elsevier
According to the β-amyloid (Aβ) hypothesis of Alzheimer's disease (AD), brain Aβ
accumulation is the primary cascade event leading to cognitive deficit and dementia …

Finding the falsification threshold of the toxic proteinopathy hypothesis in neurodegeneration

AJ Espay, K Herrup, T Daly - Handbook of Clinical Neurology, 2023 - Elsevier
A biomedical hypothesis is a theoretical assumption amenable to being tested in a
randomized clinical trial. The main hypotheses in neurodegenerative disorders are based …

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations

A Sturchio, AK Dwivedi, T Malm… - Journal of …, 2022 - journals.sagepub.com
Background: In amyloid-positive individuals at risk for Alzheimer's disease (AD), high
soluble 42-amino acid amyloid-β (Aβ42) levels are associated with normal cognition. It is …

Abandoning the proteinopathy paradigm in Parkinson disease

AJ Espay, MS Okun - JAMA neurology, 2023 - jamanetwork.com
Proteins only function in their normal state (soluble monomers) and cease to function when
transformed intocross-βfibers (insolubleamyloids). Thisisabiophysical inevitability. What is …

Peptide inhibitors of insulin fibrillation: Current and future challenges

B Rosetti, S Marchesan - International Journal of Molecular Sciences, 2023 - mdpi.com
Amyloidoses include a large variety of local and systemic diseases that share the common
feature of protein unfolding or refolding into amyloid fibrils. The most studied amyloids are …

The shift to a proteinopenia paradigm in neurodegeneration

K Ezzat, A Sturchio, AJ Espay - Handbook of Clinical Neurology, 2023 - Elsevier
The toxic proteinopathy paradigm has defined neurodegenerative disorders for over a
century. This gain-of-function (GOF) framework posited that proteins become toxic when …

[HTML][HTML] Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease

AJ Espay, AJ Lees - Parkinsonism & Related Disorders, 2024 - Elsevier
These facts argue against the gain-of-function synucleinopathy hypothesis, which proposes
that Lewy pathology causes Parkinson's disease:(1) most brains from people without …

SARS-CoV-2 and HSV-1 induce amyloid aggregation in human CSF

W Christ, S Kapell, G Mermelekas, B Evertsson, H Sork… - bioRxiv, 2022 - biorxiv.org
The corona virus (SARS-CoV-2) pandemic and the resulting long-term neurological
complications in patients, known as long COVID, have renewed the interest in the …

Models of precision medicine for neurodegeneration

AJ Espay - Handbook of Clinical Neurology, 2023 - Elsevier
The clinicopathologic model that defines neurodegenerative disorders has remained
unchanged for over a century. According to it, clinical manifestations are defined and …

SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion

W Christ, S Kapell, MJ Sobkowiak… - ACS Chemical …, 2024 - ACS Publications
The corona virus (SARS-CoV-2) pandemic and the resulting long-term neurological
complications in patients, known as long COVID, have renewed interest in the correlation …